Impaired transport of nucleotides in a mitochondrial carrier explains severe human genetic diseases.

Abstract : The mitochondrial ADP/ATP carrier (AAC) is a prominent actor in the energetic regulation of the cell, importing ADP into the mitochondria and exporting ATP toward the cytoplasm. Severe genetic diseases have been ascribed to specific mutations in this membrane protein. How minute, well-localized modifications of the transporter impact the function of the mitochondria remains, however, largely unclear. Here, for the first time, the relationship between all documented pathological mutations of the AAC and its transport properties is established. Activity measurements combined synergistically with molecular-dynamics simulations demonstrate how all documented pathological mutations alter the binding affinity and the translocation kinetics of the nucleotides. Throwing a bridge between the pathologies and their molecular origins, these results reveal two distinct mechanisms responsible for AAC-related genetic disorders, wherein the mutations either modulate the association of the nucleotides to the carrier by modifying its electrostatic signature or reduce its conformational plasticity.
Type de document :
Article dans une revue
ACS Chemical Biology, American Chemical Society, 2012, 7 (7), pp.1164-9
Liste complète des métadonnées

http://hal.univ-grenoble-alpes.fr/hal-01179684
Contributeur : Frank Thomas <>
Soumis le : jeudi 23 juillet 2015 - 10:38:56
Dernière modification le : vendredi 23 novembre 2018 - 15:02:02

Identifiants

  • HAL Id : hal-01179684, version 1
  • PUBMED : 22497660

Collections

Citation

Stéphanie Ravaud, Axel Bidon-Chanal, Iulia Blesneac, Paul Machillot, Céline Juillan-Binard, et al.. Impaired transport of nucleotides in a mitochondrial carrier explains severe human genetic diseases.. ACS Chemical Biology, American Chemical Society, 2012, 7 (7), pp.1164-9. 〈hal-01179684〉

Partager

Métriques

Consultations de la notice

170